Viewing Study NCT06145750

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2025-12-27 @ 4:27 PM
Study NCT ID: NCT06145750
Status: COMPLETED
Last Update Posted: 2025-11-24
First Post: 2023-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer
Sponsor: Delfi Diagnostics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung Cancer Screening View
None Early Diagnosis View
None Low Dose CT Scan View
None CT Scan View
None Lung Neoplasms View
None Respiratory Tract Neoplasms View
None Thoracic Neoplasms View
None Lung Diseases View
None Respiratory Tract Diseases View
None Biomarkers View
None Lung Cancer Prevention View
None Fragmentomics View
None CAT Scan View
None Early Detection View
None NSCLC View
None Adenocarcinoma View
None Lung Malignancy View
None Liquid Biopsy View
None LDCT View